Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigens produced by recombinant DNA technology.

J L Fox1, M Klass

  • 1Corporate Molecular Biology, Abbott Laboratories, Abbott Park, IL 60064.

Clinical Chemistry
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics].

Zeitschrift fur Rheumatologie·2021
Same author

[Future of acute inpatient rheumatology in Germany : Statement of the Boards of the German Society for Rheumatology and the Association of Rheumatological Acute Clinics on hospital planning North-Rhine/Westphalia 2019 for the discipline rheumatology].

Zeitschrift fur Rheumatologie·2020
Same author

Coriolis and centrifugal forces drive haltere deformations and influence spike timing.

Journal of the Royal Society, Interface·2019
Same author

Prenatal prediction of postnatal large-for-dates neonates using a simplified MRI method: comparison with conventional 2D ultrasound estimates.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2017
Same author

Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane.

International journal of pharmaceutical compounding·2013
Same author

Stability of albuterol in continuous nebulization.

International journal of pharmaceutical compounding·2013
Same journal

From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians.

Clinical chemistry·2026
Same journal

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same journal

Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

Clinical chemistry·2026
Same journal

Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

Clinical chemistry·2026
Same journal

TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

Clinical chemistry·2026
Same journal

Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

Clinical chemistry·2026
See all related articles

Recombinant DNA technology revolutionizes diagnostic reagent production, offering purer, safer, and more cost-effective viral antigens. This advancement enables new diagnostic tests and safer vaccine development.

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Biotechnology advances have significantly impacted diagnostic reagent production over the last 15 years.
  • Producers of diagnostic reagents, particularly for viral antigens, have been major beneficiaries.
  • Recombinant DNA technology offers a powerful alternative to traditional methods.

Purpose of the Study:

  • To highlight the benefits of recombinant DNA technology in producing diagnostic reagents.
  • To explore the applications of recombinant-produced antigens in diagnostics and research.
  • To discuss the implications for vaccine development.

Main Methods:

  • Cloning and expression of antigens using recombinant DNA technology.
  • Production of purified, specific, and safe antigens.

Related Experiment Videos

  • Utilizing antigens for antibody production, epitope mapping, and affinity chromatography.

    • Main Results:

    • Recombinant antigens are purer, more specific, safer, and less expensive than those from viral cultures.
    • Applications include Hepatitis B and Human Immunodeficiency Virus (HIV) diagnostic tests.
    • Enables commercial production of previously expensive antigens.
    • Facilitates development of safer vaccines.

    Conclusions:

    • Recombinant DNA technology has transformed the landscape of diagnostic reagent manufacturing.
    • The use of recombinant antigens offers significant advantages in terms of cost, safety, and specificity.
    • Further considerations are needed regarding epitope structure and immune response for vaccine applications.